Headlands Technologies’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
7,145
+5,172
+262% +$775K 0.12% 214
2026
Q1
$301K Buy
+1,973
New +$302K 0.03% 496
2024
Q2
Sell
-6,687
Closed -$647K 1470
2024
Q1
$647K Buy
+6,687
New +$686K 0.16% 157
2023
Q1
Sell
-7,901
Closed -$717K 687
2022
Q4
$717K Buy
+7,901
New +$665K 0.57% 44

Other funds holding NVS

Headlands Technologies's NVS Position: Q2 2026 in Review

Headlands Technologies increased its Novartis (NVS) stake by 262% in Q2 2026, buying an estimated $775K and bringing the position to 7,145 shares worth $1.12M. The position accounts for 0.12% of the portfolio, ranked #214.

Headlands Technologies first reported a position in NVS in Q4 2022 and has held it in 4 quarters since. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Headlands Technologies held 7,145 shares of Novartis worth $1.12M as of Q2 2026.
  • Headlands Technologies bought 5,172 Novartis shares in Q2 2026, an estimated $775K.
  • Novartis made up 0.12% of Headlands Technologies's portfolio in Q2 2026, its #214 holding.
  • Headlands Technologies first reported a position in Novartis in Q4 2022 and has held it in 4 quarters since.
  • 1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.